The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Radiomics-based prediction of response to multikinase inhibitors in radioiodine-refractory differentiated thyroid cancer patients.
 
Valentina Corino
No Relationships to Disclose
 
Elena Colombo
No Relationships to Disclose
 
Marco Bologna
No Relationships to Disclose
 
Giuseppina Calareso
No Relationships to Disclose
 
Luca Mainardi
No Relationships to Disclose
 
Stefano Cavalieri
No Relationships to Disclose
 
Daria Maria Filippini
No Relationships to Disclose
 
Carlo Resteghini
Honoraria - Sun Pharma
 
Cristiana Bergamini
No Relationships to Disclose
 
Lisa F. Licitra
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Debiopharm Group; Doxapharma; Eisai; GlaxoSmithKline; Incyte; Ipsen; Merck Serono; MSD; Nanobiotix; Novartis; Roche; SOBI
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Debiopharm Group (Inst); Eisai (Inst); Exelixis (Inst); IRX Therapeutics (Inst); Medpace (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Eisai; Merck Serono; MSD
 
Laura Deborah Locati
Honoraria - Biogen; McCann Health
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Eisai; IPSEN; Lilly; Merck Serono; MSD
Research Funding - Eisai (Inst)
Travel, Accommodations, Expenses - BMS; Eisai; Merck Serono; MSD